HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibodyWei Wang, Saburo Sone, Yasuhiko Nishioka et al.|Cancer Immunology Immunotherapy|2008Cited by 64
T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancerMehrdad Fathi, Farhad Jadidi‐Niaragh, Mohammad Hojjat‐Farsangi et al.|IUBMB Life|2021Cited by 51